Jay B Fell

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 6

Top Venues

Journal of medicinal chemistry

ACS medicinal chemistry letters

This page only lists publications with an associated author ORCID identifier.

Publications

Li Ren, David Moreno, Brian R Baer, Patrick Barbour, Tanna Bettendorf, Karyn Bouhana, Karin Brown, Suzy A Brown, Jay B Fell, Dylan P Hartley, Erik J Hicken, Ellen R Laird, Patrice Lee, Joseph McCown, Jennifer N Otten, Brett Prigaro, Ross Wallace, Dean R Kahn
Identification of the Clinical Candidate PF-07284890 ( ARRY-461 ), a Highly Potent and Brain Penetrant BRAF Inhibitor for the Treatment of Cancer. Journal of medicinal chemistry 67 (15) (2024)
Li Ren, David Moreno, Brian R Baer, Patrick Barbour, Tanna Bettendorf, Karyn Bouhana, Karin Brown, Suzy A Brown, Jay B Fell, Dylan P Hartley, Erik J Hicken, Ellen R Laird, Patrice Lee, Joseph McCown, Jennifer N Otten, Brett Prigaro, Ross Wallace, Dean R Kahn
Identification of the Clinical Candidate PF-07284890 ( ARRY-461 ), a Highly Potent and Brain Penetrant BRAF Inhibitor for the Treatment of Cancer. Journal of medicinal chemistry 67 (15) (2024)
Li Ren, David Moreno, Brian R Baer, Patrick Barbour, Tanna Bettendorf, Karyn Bouhana, Karin Brown, Suzy A Brown, Jay B Fell, Dylan P Hartley, Erik J Hicken, Ellen R Laird, Patrice Lee, Joseph McCown, Jennifer N Otten, Brett Prigaro, Ross Wallace, Dean R Kahn
Identification of the Clinical Candidate PF-07284890 ( ARRY-461 ), a Highly Potent and Brain Penetrant BRAF Inhibitor for the Treatment of Cancer. Journal of medicinal chemistry (2024)
Mohamed S A Elsayed, James F Blake, Mark L Boys, Eric Brown, Bruno D Chapsal, Mark J Chicarelli, Adam W Cook, Jay B Fell, John P Fischer, Lauren Hanson, Christine Lemieux, Matthew C Martinson, Joseph McCown, Oren T McNulty, Macedonio J Mejia, Nickolas A Neitzel, Jennifer N Otten, Martha E Rodriguez, Daniel Wilcox, Christina E Wong, Yeyun Zhou, Ronald J Hinklin
Discovery of 5-Azaquinoxaline Derivatives as Potent and Orally Bioavailable Allosteric SHP2 Inhibitors. ACS medicinal chemistry letters 14 (12) (2023)
Mohamed S A Elsayed, James F Blake, Mark L Boys, Eric Brown, Bruno D Chapsal, Mark J Chicarelli, Adam W Cook, Jay B Fell, John P Fischer, Lauren Hanson, Christine Lemieux, Matthew C Martinson, Joseph McCown, Oren T McNulty, Macedonio J Mejia, Nickolas A Neitzel, Jennifer N Otten, Martha E Rodriguez, Daniel Wilcox, Christina E Wong, Yeyun Zhou, Ronald J Hinklin
Discovery of 5-Azaquinoxaline Derivatives as Potent and Orally Bioavailable Allosteric SHP2 Inhibitors. ACS medicinal chemistry letters 14 (12) (2023)
Jay B Fell, John P Fischer, Brian R Baer, James F Blake, Karyn Bouhana, David M Briere, Karin D Brown, Laurence E Burgess, Aaron C Burns, Michael R Burkard, Harrah Chiang, Mark J Chicarelli, Adam W Cook, John J Gaudino, Jill Hallin, Lauren Hanson, Dylan P Hartley, Erik J Hicken, Gary P Hingorani, Ronald J Hinklin, Macedonio J Mejia, Peter Olson, Jennifer N Otten, Susan P Rhodes, Martha E Rodriguez, Pavel Savechenkov, Darin J Smith, Niranjan Sudhakar, Francis X Sullivan, Tony P Tang, Guy P Vigers, Lance Wollenberg, James G Christensen, Matthew A Marx
Identification of the Clinical Development Candidate MRTX849, a Covalent KRASG12C Inhibitor for the Treatment of Cancer. Journal of medicinal chemistry 63 (13) (2020)

Jay B Fell.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Jay B Fell